Cambrex Corp.

Public Company, Headquarters Location
1 Meadowlands Plz., East Rutherford, NJ 07073-2150, United States
(201)804-3000, (201)804-9852 fax, http://www.cambrex.com

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Cambrex Corporation, a Delaware corporation, began business in December 1981. Cambrex is a life sciences company dedicated to growing its portfolio of commercial small molecule therapeutics and providing products and services that accelerate and improve the discovery and commercialization of new therapeutics. The company's business is primarily comprised of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products include active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. Services include custom development and current Good Manufacturing Practices manufacturing services. The New Jersey-based company primarily supplies its products and services worldwide to pharmaceutical and generic drug companies. In January 2008, the company acquired AS ProSyntest, a privately held API research and development company located in Tallinn, Estonia. ProSyntest, renamed Cambrex Tallinn, has strengths in cost effective chemical route selection and sample generation, rapid scale up of products at kilo lab scale as well as chiral and organometallic chemistries.Manufacturing: Specialty and fine chemicals and active pharmaceutical ingredients.